|
|
Post by cretin11 on Mar 17, 2022 19:39:23 GMT -5
That is so difficult, very sorry to hear that. You’ve gone above and beyond, on the Afrezza front and in general.
|
|
|
|
Post by prcgorman2 on Mar 17, 2022 20:25:36 GMT -5
I don't think targeting the prescribing physicians help until Afrezza is insured. According to Stevil, they are educated to fall in. They are in the army now. It is health insurance. Until health insurance is explained to the American people, how it actually works, as long as we all live in Lala land, Big Pharma has their operations. Sayhey, Medicare Part D. Are they really covering Afrezza? Any chance Mike is selling Afrezza to Medicare part D at 99 dollars a month, like the program they ran for a year. You know Medicare isn't covering retail. They are covering? at 35 dollars? sweedee79 did you find anything out regarding? No I didn't... My dad is in not in a sound mental state enough to be managing his own diabetes anymore and my sister and I can't be there all of the time... He can manage his basic needs and that is about all... Doctor believed it was safest to put him on Ozempic and so far that seems to be working for him.. He had a stroke about 3 years ago.. and since then kidney failure and also congestive heart failure... We don't think he has a lot of time left.. his memory is going too now.. has mild dementia... He doesn't want to go to a nursing home so we are taking care of him the best we can at home... he also has paranoia along with the dementia so it's really really hard... Aging can be torturous for some... Insurance has been an issue with Afrezza for us and many others, but doctors don't seem to understand Afrezza either.. so I think there have been multiple problems with patients being able getting on it.. For us it took months of determination to convince the doctors and then finally the insurance removed it from their formulary.. So there you have it.. there were too many obstacles... The entire system seemed to be pushing against it because it was different... And possibly too expensive.. God bless you and your sister. That is hard and I can sympathize more than I would like having been a caregiver for a parent with chronic health issues and dementia. The fact that you’re making the effort to give him the comfort of your home(s) is comendable. Unfettered access to good medication should be a basic right. |
|
|
|
Post by mango on Mar 18, 2022 17:24:06 GMT -5
If Mike is spending less on flying hamburgers on TV I am all for that. If he is trying to get a more focused efforts with things like "Seeing is Believing" and that is going to cost less and sell more afrezza, I am all for that too. Sponsoring race cars is nice but I doubt its selling more afrezza. Sponsoring ADA activities is also probably not going to influence the ADA unless MNKD can come in with big money to buy these guys off, so spending less with the ADA is also probably a good idea because these guys are not our friends. Seeing is believing is the way to go. The people that need to see blood glucose levels ARE the public. Here is my campaign idea..... Injectable insulin. (Takes too long to work, lasts to long.)  Afrezza inhalable insulin, quick in quick out. The dosing is different.  See the difference? Time to peak effect. Time to baseline.  People on Injectable insulin do not feel good.  If only health insurance would cover it, physicians could start prescribing Afrezza. As displayed, Afrezza’s time to first measurable effect is always the same because our route of administration mimics intra-arterial administration. When combined with the monomeric insulin molecules and inert FDKP particles, Afrezza is immediately absorbed and physiologically matches endogenous first phase insulin, thus restoring the first phase insulin response that was diminished or gone. This verified and replicated thousands of times now by Afrezza Users and in clinical trials. All this possible with Afrezza causing no pain, no lipohypertrophy, no localized insulin-derived amyloidosis, no severe hypos, no severe hypers, no weight gain. Afrezza is a damn fine insulin. |
|
|
|
Post by lennymnkd on Mar 18, 2022 17:44:11 GMT -5
Lesser companies have info commercials on cable tv .. that’s what frustrates me .. is money the only obstacle .
I also know wording is of concern, but have you listen to some disclaimers in the adds produced ..ours is practically
A vegetable pill add . Cable TV , and a bigger sales force . As for the moment I think seeing is believing is great
But it must be brought to the masses…TV
|
|
|
|
Post by buyitonsale on Mar 18, 2022 23:09:01 GMT -5
TV commercials are mostly for T2D market, that is where the money is. T2 diabetics are prescribed insulin as a last resort, that is why you only see ads for drugs that precede insulin and that is the space where drug companies compete. T1D market is too small for TV ads IMO. T1D market can be addressed by targeted digital and print ads, unless you have a bunch of money to advertise "needle free" insulin on TV. Have you heard of a NEEDLE FREE insulin ? afrezza.com |
|
|
|
Post by lennymnkd on Mar 19, 2022 9:27:14 GMT -5
I settle for that (on cable) with a sound bite , hey who knows maybe a few physicians
May be watching …and could peak their intrest .
|
|
|
|
Post by sayhey24 on Mar 19, 2022 10:35:57 GMT -5
TV commercials are mostly for T2D market, that is where the money is. T2 diabetics are prescribed insulin as a last resort, that is why you only see ads for drugs that precede insulin and that is the space where drug companies compete. T1D market is too small for TV ads IMO. T1D market can be addressed by targeted digital and print ads, unless you have a bunch of money to advertise "needle free" insulin on TV. Have you heard of a NEEDLE FREE insulin ? afrezza.comThe last I checked the target market for afrezza is the early T2. In fact before the Adcom many thought afrezza would not be approved for T1s. A proper infomercial at the right price would be a good idea but it would need to be more than afrezza. It would need to be about post prandial control and how food affects BG and how diet alone for many T2s is not good enough and afrezza is needed. Partnering with someone like a Nutrisense on the infomercial is what I would do. I do think 30 second commercials demonstrating the "Seeing is Believing" challenge at the right price could be a winner if they could get enough TV time. I always wondered how the "Pillow Guy" could afford all his commercials and then found out he was getting unsold spots for next to nothing. If I were Mike I would call Mike Lindell and tell him the MNKD story and how the industry has been trying to "Cancel" the greatest advance in diabetes care in 100 years before it was approved. Who knows maybe Mike can help Mike and get him some really cheap TV spots. Lindell would probably relate to the cancel story. The way Purdue sold OC was by targeting GPs and providing a "Pain Card" which was a simple cardboard laminated card which was their own version of the SoC. The thing is they just made it up. In the case of afrezza and the "Seeing is Believing" campaign providing a similar card which after suggesting taking a walk and losing a few pounds would be to prescribe afrezza as "Step 2". If afrezza did not work then they could add the GLP1 as Step 3 and then the SGLT2 and then the other orals. The reality is most would never need the GLP1. This card would replace the SoC in the GPs office. The thing is Mike needs to make sure he has insurance coverage. The $99 a month in some cases is good enough but they will also need to bundle the 1st month with a CGM and monitoring service. Again, someone like a Nutrisense may be able to help out here. |
|
|
|
Post by prcgorman2 on Mar 19, 2022 10:41:11 GMT -5
I settle for that (on cable) with a sound bite , hey who knows maybe a few physicians May be watching …and could peak their intrest . I like it. Ghetto advertising. How about all those stupid “don’t eat this” click bait ads? Would it be possible to create an FDA-approved Afrezza click-bait ad? Can Eagle Pharmacy run click-bait ads? |
|
|
|
Post by prcgorman2 on Mar 19, 2022 10:44:34 GMT -5
TV commercials are mostly for T2D market, that is where the money is. T2 diabetics are prescribed insulin as a last resort, that is why you only see ads for drugs that precede insulin and that is the space where drug companies compete. T1D market is too small for TV ads IMO. T1D market can be addressed by targeted digital and print ads, unless you have a bunch of money to advertise "needle free" insulin on TV. Have you heard of a NEEDLE FREE insulin ? afrezza.comThe last I checked the target market for afrezza is the early T2. In fact before the Adcom many thought afrezza would not be approved for T1s. A proper infomercial at the right price would be a good idea but it would need to be more than afrezza. It would need to be about post prandial control and how food affects BG and how diet alone for many T2s is not good enough and afrezza is needed. Partnering with someone like a Nutrisense on the infomercial is what I would do. I do think 30 second commercials demonstrating the "Seeing is Believing" challenge at the right price could be a winner if they could get enough TV time. I always wondered how the "Pillow Guy" could afford all his commercials and then found out he was getting unsold spots for next to nothing. If I were Mike I would call Mike Lindell and tell him the MNKD story and how the industry has been trying to "Cancel" the greatest advance in diabetes care in 100 years before it was approved. Who knows maybe Mike can help Mike and get him some really cheap TV spots. Lindell would probably relate to the cancel story. The way Purdue sold OC was by targeting GPs and providing a "Pain Card" which was a simple cardboard laminated card which was their own version of the SoC. The thing is they just made it up. In the case of afrezza and the "Seeing is Believing" campaign providing a similar card which after suggesting taking a walk and losing a few pounds would be to prescribe afrezza as "Step 2". If afrezza did not work then they could add the GLP1 as Step 3 and then the SGLT2 and then the other orals. The reality is most would never need the GLP1. This card would replace the SoC in the GPs office. The thing is Mike needs to make sure he has insurance coverage. The $99 a month in some cases is good enough but they will also need to bundle the 1st month with a CGM and monitoring service. Again, someone like a Nutrisense may be able to help out here. Interesting. An opportunity for VDEX infomercial or click-bait ads here (where “here” could even include ProBoards)? |
|
|
|
Post by lennymnkd on Mar 19, 2022 10:47:38 GMT -5
Great post seyhey 👍 / unsold adds interesting.. I could never figure it out .. how
It was cost effective for Mike Lindell.
|
|
|
|
Post by prcgorman2 on Mar 19, 2022 10:48:50 GMT -5
Is there an unsold ad broker app?
|
|
|
|
Post by lennymnkd on Mar 19, 2022 11:05:24 GMT -5
We have the product of a lifetime for
What we are discussing…. Hope ( WE! )
Can make this work .
|
|
|
|
Post by mango on Mar 19, 2022 11:38:39 GMT -5
TV commercials are mostly for T2D market, that is where the money is. T2 diabetics are prescribed insulin as a last resort, that is why you only see ads for drugs that precede insulin and that is the space where drug companies compete. T1D market is too small for TV ads IMO. T1D market can be addressed by targeted digital and print ads, unless you have a bunch of money to advertise "needle free" insulin on TV. Have you heard of a NEEDLE FREE insulin ? afrezza.comThe last I checked the target market for afrezza is the early T2. In fact before the Adcom many thought afrezza would not be approved for T1s. A proper infomercial at the right price would be a good idea but it would need to be more than afrezza. It would need to be about post prandial control and how food affects BG and how diet alone for many T2s is not good enough and afrezza is needed. Partnering with someone like a Nutrisense on the infomercial is what I would do. I do think 30 second commercials demonstrating the "Seeing is Believing" challenge at the right price could be a winner if they could get enough TV time. I always wondered how the "Pillow Guy" could afford all his commercials and then found out he was getting unsold spots for next to nothing. If I were Mike I would call Mike Lindell and tell him the MNKD story and how the industry has been trying to "Cancel" the greatest advance in diabetes care in 100 years before it was approved. Who knows maybe Mike can help Mike and get him some really cheap TV spots. Lindell would probably relate to the cancel story. The way Purdue sold OC was by targeting GPs and providing a "Pain Card" which was a simple cardboard laminated card which was their own version of the SoC. The thing is they just made it up. In the case of afrezza and the "Seeing is Believing" campaign providing a similar card which after suggesting taking a walk and losing a few pounds would be to prescribe afrezza as "Step 2". If afrezza did not work then they could add the GLP1 as Step 3 and then the SGLT2 and then the other orals. The reality is most would never need the GLP1. This card would replace the SoC in the GPs office. The thing is Mike needs to make sure he has insurance coverage. The $99 a month in some cases is good enough but they will also need to bundle the 1st month with a CGM and monitoring service. Again, someone like a Nutrisense may be able to help out here. ADA is a Pay to Play Scheme. Also, Eli Lilly, Novo, and Sanofi all make political donations to influence and manipulate regulatory decision making in their favor. MannKind has to think outside the box if they want to win. What you have suggested may be a good step in the right direction. I sure hope michaelcastagna has a “Seeing is Believing” live demonstration at the booth this year. |
|
|
|
Post by nylefty on Mar 19, 2022 16:43:37 GMT -5
There's no way to have a 30 second Afrezza commercial. The black box warnings would take up almost all of the time.
|
|
|
|
Post by boca1girl on Mar 19, 2022 21:41:38 GMT -5
I think this thread has gotten way off topic and probably time to lock it.
Moderators?
|
|
